« Lilly's R&D Outsourcing |
| Extortion, Retractions, And More »
January 6, 2010
Five Technologies For the Scrap Heap?
Xconomy has a piece on biotechnologies that look to be headed for obsolescence. I think the list is mostly correct - it includes the raw proteomic approach to understanding disease states and a lot of the biomarker work being done currently. I won't spoil the rest of the list; take a look and see what you think. Note: RNA interference is not on it, in case you're wondering. Nor are stem cells.
+ TrackBacks (0) | Category: Biological News
POST A COMMENT
- RELATED ENTRIES
- The Baran Group Blog (And Some Others?)
- Suing A Generic Drug Maker: When And How?
- Biopharma Startups in India and China - Do They Exist?
- I'll Just Take a Tour of Your Lab Drawers Here
- Peter Kim Retires From Merck
- Probing A Binding Tunnel With AFM
- Safety Warning: Togni's Reagents
- Anonymity, Fakery, et al.